According to the report by Emergen Research The global Cell and Gene Therapy Market is expected to reach USD 6,570.0 Million by 2027, The study further serves as a unique research for stakeholders, product owners, and field marketing executives looking for actionable data and unique resource on market size, share, and growth
Read The Detailed Report@ https://www.emergenresearch.com/industry-report/cell-and-gene-therapy-market
The study finds that how on certain account threats and challenges can act as a roadblock for the business.
Key Points Of The Report:
- North America held the largest share of the market in 2019. The gene therapy market in the US is the main market for gene therapy-related clinical trials, with about 60 percent of all clinical trials globally being performed in the region.
- Key participants include Spark Therapeutics LLC, Novartis AG, Gilead Sciences Inc., Bluebird Bio, GlaxoSmithKline, Celgene Corporation, Shire PLC, Sangamo Biosciences, Voyager Therapeutics, and Dimension Therapeutics, among others.
Emergen Research has segmented the global Cell and Gene Therapy Market on the basis of indication, vector type:
- Indication Outlook (Revenue, USD Billion; 2017-2027)
- Acute Lymphoblastic Leukemia (ALL)
- Inherited Retinal Disease
- Large B-Cell Lymphoma
- ADA-SCID
- Others
- Vector Outlook (Revenue, USD Billion; 2017-2027)
- Lentivirus
- AAV
- Retrovirus & Gammaretrovirus
- Modified Herpes Simplex Virus
- Adenovirus
- Non-Viral Plasmid Vector
Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Cell and Gene Therapy Market Segmentation & Impact Analysis
4.1. Cell and Gene Therapy Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Robust gene therapy pipeline
4.2.2.2. Introduction of technological advancements
4.2.2.3. Increasing investment from the companies and partnerships
4.2.2.4. Growing prevalence of target diseases and increased demand for innovative medicine
4.2.3. Market restraints analysis
4.2.3.1. Regulatory, scientific, and ethical challenges associated with gene therapy
4.2.3.2. High prices of gene therapy medicines
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Continued…